Skip to main content

Precision Medicine in Oncology: No Two Tumors Alike

The Scientist is bringing together a panel of experts to explore where precision oncology is currently positioned in cancer therapy and to discuss where it could be going.

Event Details:Precision Medicine in Oncology: No Two Tumors AlikeDate(s):

Precision Medicine in Oncology: No Two Tumors Alike from thescientistllc on Vimeo.

Most cancers arise from abnormal genes or gene regulation. These abnormalities can occur through inheritance, from environmental insults, or via random mutation. The genetic changes that allow tumors to grow and spread differ between individuals even when they have the same cancer type and stage. Therefore, two people with the same cancer type given the same therapeutic may respond differently based on their cancer’s genetics. Precision medicine allows more targeted therapies, leveraging genetic information about tumor pathogenesis. The precision medicine approach, however, is not yet part of routine care for most cancer patients. To explore where precision oncology is currently positioned in cancer therapy, and to discuss where it could be going, The Scientist is bringing together a panel of experts in the field for this free educational webinar.

Topics to be covered:

Sofia Merajver, MD, PhD
Professor, Epidemiology, and Dept. of Internal Medicine
Director, Breast and Ovarian Cancer Risk and Evaluation Program
University of Michigan, School of Public Health

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo